Treatment of dystonia

Parkinsonism and Related Disorders

Volumn 13, Issue SUPPL. 3, 2007, Pages

  Adam, Octavian R ^a   Jankovic, Joseph ^a  

^a Parkinson's Disease Center   (United States)

Author keywords

Botulinum toxin; Deep brain stimulation; Dystonia; Treatment

Indexed keywords

4 HYDROXYBUTYRIC ACID; BACLOFEN; BENZATROPINE; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CARBAMAZEPINE; CEVIMELINE; CLONAZEPAM; CYCLOBENZAPRINE; DIAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; LEVODOPA; LORAZEPAM; MEXILETINE; MORPHINE SULFATE; PILOCARPINE; PROSIGNE; PYRIDOSTIGMINE; TETRABENAZINE; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ADVERSE OUTCOME; AKATHISIA; ANXIETY; ARTICLE; BASAL GANGLION; BEDTIME DOSAGE; BLEPHAROSPASM; BLURRED VISION; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; CERVICAL DYSTONIA; COGNITIVE DEFECT; CONFUSION; COUGHING; DENERVATION; DEPRESSION; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DYSARTHRIA; DYSTONIA; ECCHYMOSIS; EXTRADURAL RAMISECTOMY; EXTRAPYRAMIDAL SYMPTOM; FOCAL DYSTONIA; GAIT DISORDER; GENE THERAPY; GENERALIZED DYSTONIA; GLOBUS PALLIDUS; GLOBUS PALLIDUS INTERNUM; HALLUCINATION; HEADACHE; HEART ARRHYTHMIA; HUMAN; INFECTION; INSOMNIA; INTRADURAL ANTERIOR RHIZOTOMY; MEMORY DISORDER; MUSCLE RESECTION; MYECTOMYMYOTOMY; NAUSEA AND VOMITING; NERVOUSNESS; NEUROSURGERY; OCCUPATIONAL THERAPY; ORBICULARIS OCULI MYECTOMY; OROMANDIBULAR DYSTONIA; PARKINSONISM; PATHOPHYSIOLOGY; PERIPHERAL SURGICAL DENERVATION; PRIORITY JOURNAL; PTOSIS; REFRACTORY DYSTONIA; RHIZOTOMY; SEGMENTAL DYSTONIA; SEIZURE; SIDE EFFECT; SPASMODIC DYSTONIA; STATUS DYSTONICUS; SUBDURAL HEMATOMA; SYNCOPE; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DEEP BRAIN STIMULATION; DYSTONIA; GENE THERAPY; HUMANS;

EID: 38949132571     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(08)70031-2     Document Type: Article

References (27)

1. Mariotti P., Fasano A., Contarino M., Della Marca G., Piastra M., Genovese O., et al. Management of status dystonicus: our experience and review of the literature. Mov Disord 22 (2007) 963-968
2. Jankovic J. Treatment of dystonia. Lancet Neurol 5 10 (2006) 864-872
3. Kenney C., Hunter C., and Jankovic J. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 22 2 (2007) 193-197
4. Hou J., Ondo W., and Jankovic J. Intrathecal baclofen for dystonia. Mov Disord 16 6 (2001) 1201-1202
5. Lotze T., and Jankovic J. Paroxysmal kinesigenic dyskinesias. Semin Ped Neurol 10 (2003) 68-79
6. Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 75 (2004) 951-957
7. Simpson D., Naumann M., Blitzer A., Brashear A., Comella C., Dubinsky R., et al. Assessment: botulinum neurotoxin for the treatment of movement disorders and spasticity: and evidence-based report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology (2007) in press.
8. Comella C., Jankovic J., Shannon K., Tsui J., Swenson M., Leurgans S., et al. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 65 (2005) 1423-1429
9. Tintner R., Gross R., Winzer U., Smalky K., and Jankovic J. Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial. Neurology 65 (2005) 765-767
10. Jankovic J., Hunter C., Dolimbek B., Dolimbek G., Adler C., Brashear A., et al. Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia. Neurology 67 (2006) 2233-2235
11. Jost W., Blumel J., and Graft S. Botulinum neurotoxin type A free of complexing proteins (Xeomin) in focal dystonia. Drugs 67 5 (2007) 669-683
12. Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm, in press.
13. Roggenkamper P., Jost W., Bihari K., Comes G., and Grafe S. Efficacy and safety of a new botulinum toxin A free of complexing proteins in the treatment of blepharospasm. J Neural Transm 113 3 (2006) 303-312
14. Rieder C., Schestatsky P., Socal M., Monte T., Fricke D., Costa J., et al. A double-blind, randomized, crossover study of Prosigne versus Botox in patients with blepharospasm and hemifacial spasm. Clin Neuropharmacol 30 1 (2007) 39-42
15. Bielamowicz S., Stager S., Badillo A., and Godlewski A. Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia. J Voice 16 1 (2002) 117-123
16. Sitburana O, Jankovic J. Focal hand dystonia, mirror dystonia and motor overflow. J Neurol Sci 2007 Sep 19 [Epub ahead of print].
17. Mejia N., Vuong K., and Jankovic J. Long-term botulinum toxin efficacy, safety and immunogenicity. Mov Disord 20 (2005) 592-597
18. Vidailhet M., Vercueil L., Houeto J., Krystkowiak P., Benabid A., Cornu P., et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 352 5 (2005) 459-467
19. Vidailhet M., Vercueil L., Houeto J., Krystkowiak P., Lagrange C., Yelnik J., et al. Bilateral, pallidal, deep-brain stimulation in primary generalized dystonia: a prospective 3 year follow-up study. Lancet Neurol 6 3 (2007) 223-229
20. Hung S., Hamani C., Lozano A., Poon Y.-Y., Piboolnurak P., Miyasaki J., et al. Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology 68 (2007) 457-459
21. Ostrem J., Marks Jr. W., Voltz M., Heath S., and Starr P. Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome). Mov Disord 22 13 (2007) 1885-1891
22. Fukaya C., Otaka T., Obuchi T., Kano T., Nagaoka T., Kobayashi K., et al. Pallidal high-frequency deep brain stimulation for camptocormia: an experience of three cases. Acta Neurochir Suppl 99 (2006) 25-28
23. Kleiner-Fisman G., Lin Liang G., Moberg P., Ruocco A., Hurtig H., Baltuch G., et al. Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. J Neurosurg 107 (2007) 29-36
24. Sun B., Chen S., Zhan S., Le W., and Krahl S. Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl 97 (2007) 207-214
25. Kenney C., Simpson R., Hunter C., Ondo W., Almaguer M., Davidson A., et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 106 (2007) 621-625
26. Foncke E., Schuurman P., and Speelman J. Suicide after deep brain stimulation of the internal globus pallidus for dystonia. Neurology 66 (2006) 142-143
27. Gonzalez-Alegre P., Bode N., Davidson B., and Paulson H. Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia. J Neurosci 25 45 (2005) 10502-10509